America Stem Cell, Inc. Receives FDA Clearance for Its Multi-Center Nationwide Trial

America Stem Cell, Inc. announced today it has received clearance from FDA for its Phase I/IIa nationwide multi-center dual-umbilical cord transplantation study evaluating ASC-101 in patients with hematologic malignancies and myelodysplastic syndrome.

http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20130905005368&newsLang=en&ndmConfigId=1000639&vnsId=41